We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Black Carbon Nanoparticles Modify Pathogens and Affect Resistance

By LabMedica International staff writers
Posted on 14 Mar 2017
Nanoparticles of black carbon, one of the main components of air pollution, have been found to modify the way bacterial pathogens grow in vitro and in vivo and to significantly increase their resistance to treatment with certain antibiotics.

While the effects of the particulate matter in air pollution on human health are well established, the effects on bacteria – organisms central to ecosystems in humans and in the natural environment – are poorly understood.

To fill this gap, investigators at the University of Leicester examined the effect of black carbon particles on two human pathogens, Staphylococcus aureus and Streptococcus pneumoniae, which are both major causes of respiratory diseases and exhibit high levels of resistance to antibiotics.

The investigators reported in the February 28, 2017, online edition of the journal Environmental Microbiology that black carbon drastically changed the development of bacterial biofilms, key aspects of bacterial colonization and survival. More...
Results showed that exposure to black carbon induced structural, compositional, and functional changes in the biofilms of both S. pneumoniae and S. aureus. Black carbon differentially altered the tolerance of biofilms to proteolytic degradation and multiple antibiotics, increasing S. pneumoniae survival against penicillin, the front line treatment of bacterial pneumonia.

In addition, the results revealed that black carbon impacted bacterial colonization in the body. In a mouse nasopharyngeal colonization model, black carbon caused S. pneumoniae to spread from the nasopharynx to the lungs, which is essential for subsequent infection.

Senior author Dr. Julie Morrissey, associate professor of microbial genetics at the University of Leicester, said, "This work increases our understanding of how air pollution affects human health. It shows that the bacteria, which cause respiratory infections, are affected by air pollution, possibly increasing the risk of infection and the effectiveness of antibiotic treatment of these illnesses. Our research could initiate an entirely new understanding of how air pollution affects human health. It will lead to enhancement of research to understand how air pollution leads to severe respiratory problems and perturbs the environmental cycles essential for life."


Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic Hematology Analyzer
DH-800 Series
Sample Transportation System
Tempus1800 Necto
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Industry

view channel
Image: The LIAISON NES molecular point-of-care platform (Photo courtesy of Diasorin)

Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform

Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.